HRP930004A2 - Animal food, an additive to it, or to drinking water, containing the antibiotic mixture of gentamicin with lincomycin or clindamycin - Google Patents
Animal food, an additive to it, or to drinking water, containing the antibiotic mixture of gentamicin with lincomycin or clindamycin Download PDFInfo
- Publication number
- HRP930004A2 HRP930004A2 HR930004A HRP930004A HRP930004A2 HR P930004 A2 HRP930004 A2 HR P930004A2 HR 930004 A HR930004 A HR 930004A HR P930004 A HRP930004 A HR P930004A HR P930004 A2 HRP930004 A2 HR P930004A2
- Authority
- HR
- Croatia
- Prior art keywords
- mass
- lincomycin
- drinking water
- gentamicin
- clindamycin
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 50
- 229960002518 gentamicin Drugs 0.000 title claims description 26
- 235000020188 drinking water Nutrition 0.000 title claims description 25
- 239000003651 drinking water Substances 0.000 title claims description 25
- 229930182566 Gentamicin Natural products 0.000 title claims description 22
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 title claims description 20
- 239000000203 mixture Substances 0.000 title claims description 20
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 title claims description 17
- 230000003115 biocidal effect Effects 0.000 title claims description 17
- 229960005287 lincomycin Drugs 0.000 title claims description 17
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title claims description 17
- 235000013305 food Nutrition 0.000 title claims description 16
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 title claims description 14
- 229960002227 clindamycin Drugs 0.000 title claims description 12
- 239000000654 additive Substances 0.000 title claims description 4
- 230000000996 additive effect Effects 0.000 title claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 33
- 230000037396 body weight Effects 0.000 claims description 22
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 238000011321 prophylaxis Methods 0.000 claims description 10
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 claims description 9
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 claims description 9
- 229960001595 lincomycin hydrochloride Drugs 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 244000144977 poultry Species 0.000 claims description 8
- 238000002560 therapeutic procedure Methods 0.000 claims description 8
- 235000019786 weight gain Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 5
- 229960001200 clindamycin hydrochloride Drugs 0.000 claims 1
- 238000009374 poultry farming Methods 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 description 38
- 235000013330 chicken meat Nutrition 0.000 description 33
- 229940088710 antibiotic agent Drugs 0.000 description 28
- 230000034994 death Effects 0.000 description 11
- 231100000517 death Toxicity 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 229960000268 spectinomycin Drugs 0.000 description 8
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 6
- 235000013594 poultry meat Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 206010003445 Ascites Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010006895 Cachexia Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000283903 Ovis aries Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229960003022 amoxicillin Drugs 0.000 description 3
- 229960004920 amoxicillin trihydrate Drugs 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 3
- 238000003307 slaughter Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241000272517 Anseriformes Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 description 2
- LKKVGKXCMYHKSL-LLZRLKDCSA-N gentamycin A Chemical compound O[C@H]1[C@H](NC)[C@@H](O)CO[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N LKKVGKXCMYHKSL-LLZRLKDCSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- CEAZRRDELHUEMR-CAMVTXANSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1r)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1[C@H]([C@@H](C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-CAMVTXANSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 241000223203 Coccidioides Species 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ONXOKWFYBIQOFQ-VSXSCALHSA-N ac1l4s0d Chemical compound OS(O)(=O)=O.O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O.O[C@@H]1[C@H](O)[C@@H](O)[C@@H](SC)O[C@@H]1[C@@H]([C@@H](C)O)NC(=O)[C@H]1N(C)C[C@H](C(C)C)C1 ONXOKWFYBIQOFQ-VSXSCALHSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 229930076781 gentamycin C1 Natural products 0.000 description 1
- VEGXETMJINRLTH-BOZYPMBZSA-N gentamycin C1a Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-BOZYPMBZSA-N 0.000 description 1
- XUFIWSHGXVLULG-JYDJLPLMSA-N gentamycin C2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-JYDJLPLMSA-N 0.000 description 1
- 239000003324 growth hormone secretagogue Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Saccharide Compounds (AREA)
Description
Oblast tehnike u koju spada izum The technical field to which the invention belongs
Predmet izuma spada u oblast veterine, a naročito u oblast ishrane životinja. The subject of the invention belongs to the field of veterinary medicine, and especially to the field of animal nutrition.
Prema Međunarodnoj klasifikaciji patenata (MKP) predmet izuma je razvrstan, odnosno klasiran i označen klasifikacionim simbolom A23K 1/17 kojim je definirana stočna hrana sa antibioticima. Kao što se vidi, izum pripada u područje veterine, te se odnosi na životinjsku hranu te dodatak njoj, koja sadrži antibiotsku mješavinu gentamicina sa linkomicinom ili gentamicina sa klindamicinom, koji mogu biti u obliku slobodnih baza, ali uvijek prvenstveno u obliku njihovih farmakološko prihvatljivih kiselinskih adicijskih soli, za profilaksu i terapiju infekcija i posljedično za povećanje prirasta tjelesne mase kod tovljenih životinja kao i na postupak za profilaksu i terapiju infekcija, te kao posljedica za povećanje prirasta tjelesne mase kod tovljenih životinja. According to the International Classification of Patents (IPC), the subject of the invention is classified, i.e. classified and marked with the classification symbol A23K 1/17, which defines animal feed with antibiotics. As can be seen, the invention belongs to the field of veterinary medicine, and relates to animal food and its addition, which contains an antibiotic mixture of gentamicin with lincomycin or gentamicin with clindamycin, which can be in the form of free bases, but always primarily in the form of their pharmacologically acceptable acid of addition salts, for prophylaxis and therapy of infections and consequently for increasing body weight gain in fattened animals as well as for the procedure for prophylaxis and therapy of infections, and as a consequence for increasing body weight gain in fattened animals.
Tehnički problem Technical problem
Postoji stalna potreba za učinkovitu profilaksu i terapiju infekcije i posljedično za povećanje prirasta tjelesne mase kod tovljenih životinja, kao što su perad, telad, prasad, janjad i u tu svrhu se traže antibiotici, odnosno kombinacija antibiotika kao dodatak stočnoj hrani ili pitkoj vodi, s kojima bi dospjeli do željenog uspjeha. There is a constant need for effective prophylaxis and treatment of infection and, consequently, for increasing body weight gain in fattened animals, such as poultry, calves, piglets, lambs, and for this purpose, antibiotics are sought, or a combination of antibiotics as an addition to animal feed or drinking water, with which would reach the desired success.
Stanje tehnike State of the art
Linkomicin je poznat antibiotik, koji je bio opisan u US patentu br. 3086912, što koči rast i razmnožavanje brojnih mikroorganizama, pogotovo gram pozitivnih bakterija. U US patentu br.3155580 su opisani galenski oblici na osnovu linkomicina odnosno njegovih kiselinskih adicijskih soli, kao aktivnog ingredijenta za liječenje infekcija prouzrokovanih bakterijama kod ljudi i životinja. Kod tovljenih životinja se antibiotik može upotrijebiti profilaktično, odnosno za prirast tjelesne mase kao stimulator rasta. Linkomicin hidroklorid može se davati u uobičajenu hranu u dozirnim jedinicama. Lincomycin is a known antibiotic, which was described in US patent no. 3086912, which inhibits the growth and reproduction of numerous microorganisms, especially gram-positive bacteria. US patent no. 3155580 describes galenic forms based on lincomycin, i.e. its acid addition salts, as an active ingredient for the treatment of infections caused by bacteria in humans and animals. In fattened animals, the antibiotic can be used prophylactically, i.e. to increase body weight as a growth stimulator. Lincomycin hydrochloride can be administered in common food in dosage units.
Iz US patenta br. 3150042 je poznata upotreba linkomicina za profilaktično i terapeutsko liječenje kokcidioze kod životinja, kod čega upotrebljavaju antibiotike kao dodatak običnoj životinjskoj hrani ili ka primjerenoj količini pitke vode. Opisane je još upotreba tableta i sterilnih inekcijskih rastopina. From US patent no. 3150042 is the known use of lincomycin for the prophylactic and therapeutic treatment of coccidiosis in animals, where antibiotics are used as an addition to ordinary animal feed or to an appropriate amount of drinking water. The use of tablets and sterile injection solutions is also described.
Klindamicin je generički naziv za 7(S)-kloro-7-deoksi-linkomicin, koji je bio opisan u američkim patentima br. 3475407, br. 3496163, br. 3509127 i br. 3539689 kao baza, ili kao njegove kiselinske adicijske soli koje se u oralnim ili parentaralnim galenskim oblicima upotrebljava kod liječenja ljudi i životinja, inficiranih s bakterijama kokcidio i mikroplazmom. Clindamycin is the generic name for 7(S)-chloro-7-deoxy-lincomycin, which was described in US Pat. Nos. 3475407, no. 3496163, no. 3509127 and no. 3539689 as a base, or as its acid addition salts, which in oral or parenteral galenic forms are used in the treatment of humans and animals, infected with coccidio bacteria and microplasma.
Terapeutski oblici klindamicina se upotrebljavaju slično kao i klindemicinovi, samo da je klindemicin djelotvoran još na plazmodije i još učinkovitiji protiv bakterijskih infekcija. Također se upotrebljava profilaktično, kao dodatak hrani kod tovljene stoke. Therapeutic forms of clindamycin are used similarly to clindamycin, except that clindamycin is effective against plasmodia and even more effective against bacterial infections. It is also used prophylactically, as a feed supplement for fattened cattle.
Gentamicin je antibiotik, koji je bio opisan u američkim patentima br. 3091572 i br. 3136704 te se sastoji iz tri strukturno srodnih komponenata, gentamicin C1,C2 i C1a. Poznat je još gentamicin A, koji se razlikuje od ostalih komponenata kompleksa. U galenskim oblicima gentamicin nastupa u obliku sulfata (gentamicin sulfat). Gentamicin is an antibiotic, which was described in US patents no. 3091572 and no. 3136704 and consists of three structurally related components, gentamicin C1, C2 and C1a. Gentamicin A is also known, which differs from the other components of the complex. In galenic forms, gentamicin occurs in the form of sulfate (gentamicin sulfate).
Gentamicin je vrlo djelotvoran antibiotik protiv gram-pozitivnih i gram-negativnih mikroorganizama, kao što su vrste stafilokoka, klebsiela, pneunomonasa i proteusa, te se upotrebljava kako u humanoj medicini tako i veterini. Gentamicin is a very effective antibiotic against gram-positive and gram-negative microorganisms, such as types of staphylococcus, Klebsiella, pneumomonas and proteus, and is used both in human medicine and in veterinary medicine.
U US patentu br. 3261687 je opisana životinjska hrana i postupak za povećanje tjelesne mase kod zdravih tovljenih životinja u omjeru 1 do 10 masenih dijelova spektinomicina i 1-og masenog dijela linkomicina u sastavu životinjske hrane. Navode, da su tom kombinacijom antibiotika u životinjskoj hrani ili pitkoj vodi postigli neočekivano dobre rezultate u povećanju prirasta tjelesne mase i brzine dostizanja iste, kao i u povećanju faktora uspješnosti. Istodobno kombinacija antibiotika u životinjskoj ishrani djeluje sinergistički, te je primjerena još za terapijska i profilaktička liječenja peradi, svinja, ovaca i goveda. In US patent no. 3261687 describes animal feed and a procedure for increasing body weight in healthy fattened animals in a ratio of 1 to 10 parts by mass of spectinomycin and 1 part by mass of lincomycin in the composition of animal feed. They state that with this combination of antibiotics in animal feed or drinking water, they achieved unexpectedly good results in increasing body mass gain and speed of reaching it, as well as in increasing the success factor. At the same time, the combination of antibiotics in animal nutrition acts synergistically, and is also suitable for therapeutic and prophylactic treatment of poultry, pigs, sheep and cattle.
Opis rješenja tehničko problema Description of solutions to technical problems
Izum se temelji na zadaći naći djelotvornu mješavinu antibiotika kao dodatak životinjskoj hrani ili pitkoj vodi za životinje kao što su perad, svinje, telad i janjad, koja bi bila djelotvorna u profilaksi i terapiji infekcija, te bi time posljedično na brz način povećali prirast tjelesne mase tovljenih životinja i faktor uspješnosti uz nisku konverziju hrane. The invention is based on the task of finding an effective mixture of antibiotics as an addition to animal feed or drinking water for animals such as poultry, pigs, calves and lambs, which would be effective in the prophylaxis and therapy of infections, and would consequently increase body weight gain quickly. fattening animals and success factor with low feed conversion.
Rezultati što bi ih dobili s novom mješavinom antibiotika, kao dodatku životinjskoj hrani ili pitkoj vodi, bili bi bolji od rezultata dobivenih s upotrebom pojedinih antibiotika, odnosno bili bi bolji i od neke poznate kombinacije antibiotika za iste svrhe, kao u gore navedenom US patentu br. 3261687 spomenuta kombinacija linkomicinspektinomicin, što bi predstavljalo značajno poboljšanje kod uzgoja životinja. The results obtained with a new mixture of antibiotics, as an additive to animal feed or drinking water, would be better than the results obtained with the use of individual antibiotics, that is, they would be better than some known combination of antibiotics for the same purposes, as in the above-mentioned US patent no. . 3261687 mentioned the combination of lincomycin-inspektinomycin, which would represent a significant improvement in animal husbandry.
S iznenađenjem smo ustanovili, da traženi cilj dostignemo s mješavinom antibiotika gentamicina s linkomicinom ili gentamicina s klindamicinom, prvenstveno u obliku njihovih kiselinskih adicijskih soli, kao što je mješavina gentamicin sulfata i linkomicin hidroklorida, te ih dodajemo u uobičajenu životinjsku hranu ili pitku vodu. We were surprised to find that the required goal can be achieved with a mixture of antibiotics gentamicin with lincomycin or gentamicin with clindamycin, primarily in the form of their acid addition salts, such as a mixture of gentamicin sulfate and lincomycin hydrochloride, and we add them to common animal feed or drinking water.
Ustanovili smo, da postižemo djelotvorne profilaktične i terapijske učinke i kao posljedicu najveću konačnu tjelesnu masu s tovljenim životinjama kao peradi, koja u vodi za piće ili u običnoj hrani sadrži kombinaciju gentamicina s linkomicinom ili klindamicinom. Pogotovo djelotvorna je mješavina gentamicin sulfata s linkomicin hidrokloridom. We found that we achieve effective prophylactic and therapeutic effects and, as a result, the highest final body mass with fattening animals such as poultry, which in drinking water or in ordinary food contains a combination of gentamicin with lincomycin or clindamycin. A mixture of gentamicin sulfate with lincomycin hydrochloride is especially effective.
U usporedbi s primjenom poznate mješavine antibiotika spektinomicinom i linkomicina (Linco - Spectin 100, the Upjohn Comp., USA) u životinjskoj hrani, kao i pitkoj vodi, odnosno s pojedinim antibioticima ima nova mješavina antibiotika u smislu izuma u uzgoju životinja pored većeg prirasta tjelesne mase i manjeg uginuća, također je najviši faktor uspješnosti. Poboljšani rezultati, koje su testovi pokazali s novom mješavinom antibiotika u usporedbi s poznatom kombinacijom linkomicin-spektinomicin, su bili stvarno iznenađujući i to utoliko više, jer do za postizanje poboljšanih rezultata došlo već s vrlo malim udjelom gentamicina u kombinaciji s linkomicinom. In comparison with the use of the well-known mixture of antibiotics spectinomycin and lincomycin (Linco - Spectin 100, the Upjohn Comp., USA) in animal feed, as well as in drinking water, that is, with certain antibiotics, there is a new mixture of antibiotics in the sense of the invention in animal breeding, in addition to a greater increase in body weight mass and less death, is also the highest success factor. The improved results, which the tests showed with the new antibiotic mixture compared to the known lincomycin-spectinomycin combination, were really surprising, and all the more so, because the improved results were already achieved with a very small proportion of gentamicin in combination with lincomycin.
Ustanovljeni rezultati su značajni također iz ekonomskog gledišta, jer postižemo kod uzgoja tovljenih životinja uz upotrebu nove mješavine antibiotika veći prirast tjelesne mase manja uginuća i viši faktor uspješnosti, uz istovremeno manji ukupni utrošak obaju antibiotika. The established results are also significant from an economic point of view, because when breeding fattened animals with the use of a new mixture of antibiotics, we achieve a higher increase in body weight, lower mortality and a higher success factor, with at the same time a lower total consumption of both antibiotics.
Poboljšane rezultate postižemo i s upotrebom nove mješavine antibiotika kod uzgoja tovljenih životinja, kao što su telad, prasad, janjad i perad (pilići, patke, guske, purani). Antibiotike dodajemo u uobičajenu životinjsku hranu ili pitku vodu u omjeru 1 maseni dio gentamicina i 5 do 60 masenih dijelova linkomicina ili klindamicina, povoljnije u obliku njihovih kiselinskih adicijskih soli. We also achieve improved results with the use of a new mixture of antibiotics in the breeding of fattened animals, such as calves, piglets, lambs and poultry (chickens, ducks, geese, turkeys). Antibiotics are added to common animal feed or drinking water in a ratio of 1 mass part of gentamicin and 5 to 60 mass parts of lincomycin or clindamycin, preferably in the form of their acid addition salts.
Dozu nove mješavine antibiotika u hrani ili pitkoj vodi odredimo prema vrsti životinja, starosti, težini i prosječnoj dnevnoj količini utrošene hrane, odnosno pitke vode. The dose of the new mixture of antibiotics in food or drinking water is determined according to the type of animal, age, weight and average daily amount of food or drinking water consumed.
Mješavinu antibiotika možemo upotrebljavati u obliku čistih komponenata, ali kao povoljnije pripremimo tekući ili kruti premiks, to jest u obliku koncentrata, prije dodatka hrani ili pitkoj vodi. Kruti premiks možemo pripremiti miješanjem antibiotika s krutim diluentimom kao laktozom, škrobom, brašnom odnosno sojinim brašnom, kalcijevim karbonatom i drugima, kojeg dodajemo hrani ili dispergirano u pitku vodu. We can use the antibiotic mixture in the form of pure components, but it is more convenient to prepare a liquid or solid premix, that is, in the form of a concentrate, before adding it to food or drinking water. We can prepare a solid premix by mixing antibiotics with a solid diluent such as lactose, starch, flour or soy flour, calcium carbonate and others, which we add to food or disperse in drinking water.
Uobičajena životinjska hrana može sadržavati još dodatke kao jodirana sol, vitamine A, B, C ili D i ostale primjerne soli, minerale, konzervanse..... Common animal food can also contain additives such as iodized salt, vitamins A, B, C or D and other exemplary salts, minerals, preservatives.....
Nova kombinacija antibiotika djeluje sinergistično u profilaksi i terapiji kod infekcija životinja s mikroparazitima, uključivo bakterijama, kokcidio i mikroplazmom, pogotovo pak do pojedinih bakterija. The new combination of antibiotics works synergistically in the prophylaxis and therapy of animal infections with microparasites, including bacteria, coccidioides and microplasma, especially with certain bacteria.
Izum objašnjavaju, ali s ničim ne ograničavaju slijedeća dva primjera: The invention is explained, but not limited by the following two examples:
Primjer 1 Example 1
Uspoređujuće testiranje antibiotika gentamicina, kombinacija linkomicin - gentamicin, kombinacija linkomicin - spektinomicin i amoksicilina kod brojlera. Comparative testing of antibiotics gentamicin, combination lincomycin - gentamicin, combination lincomycin - spectinomycin and amoxicillin in broilers.
Izveli smo uspoređivačko testiranje navedenih antibiotika kod brojlera, s kojima smo željeli ustanoviti prirast tjelesne mase, brzine rasta i faktor uspješnosti. Antibiotike smo aplicirali u obliku komercijalnih preparata i to gentamicin prašak (LEK-Ljubljana, YU) s sadržajnošću od 10% gentamicina, linkomicin-spektinomicin (Linco-SpectinR 100, firme Upjohn Comp. USA) i amoksicilin (SimivetR-Pliva YU). Kombinaciju antibiotika u smislu pronalaska Linkomicin-gentamicin smo aplicirali u obliku premiksa s laktozom i praškastim polietilenglikolom 400. We performed comparative testing of the mentioned antibiotics in broilers, with which we wanted to determine the increase in body weight, growth rate and success factor. Antibiotics were applied in the form of commercial preparations, namely gentamicin powder (LEK-Ljubljana, YU) with a content of 10% gentamicin, lincomycin-spectinomycin (Linco-SpectinR 100, company Upjohn Comp. USA) and amoxicillin (SimivetR-Pliva YU). We applied the antibiotic combination according to the invention Lincomycin-gentamicin in the form of a premix with lactose and powdered polyethylene glycol 400.
U donjoj tabeli 1 navedene koncentracije antibiotika su proračunate obzirom na udio pojedinih antibiotika u preparatima, odnosno premiksa. U pokus smo uključili 69600 pilića provenijencije ARBOR-ACRES, izleglih iz jaja jedne skupine roditelja u istom vremenskom razdoblju, smjestili smo ih u 4 objekta (C1, C2, C3 i C4) sa 17400 pilića po objektu. In table 1 below, the listed concentrations of antibiotics are calculated taking into account the proportion of individual antibiotics in the preparations, that is, the premix. In the experiment, we included 69,600 chickens of ARBOR-ACRES provenance, hatched from the eggs of one group of parents in the same time period, we placed them in 4 facilities (C1, C2, C3 and C4) with 17,400 chickens per facility.
Životinje su prva tri dana života, te 13, 14 i 15 dan dobivale određen antibiotik u vodi za piće, što je vidljivo iz tabele 1. The animals were given a specific antibiotic in their drinking water for the first three days of life, and on days 13, 14 and 15, as can be seen from Table 1.
Tabela l. Table l.
[image] [image]
13, 14 i 15 dan starosti pilići su dobivali više koncentracije antibiotika, samo smo u objektu C4 koncentraciju amoksicilin trihidrata povisili na 5 g na 100 litara vode za piliće. At the age of 13, 14 and 15 days, the chickens received a higher concentration of antibiotics, only in facility C4 we increased the concentration of amoxicillin trihydrate to 5 g per 100 liters of water for chickens.
Objekte, u koje smo naselili životinje za testiranje smo dezinfici rali pomoću slijedećih aktivnosti: mehaničko čišćenje, ispiranje hladnom vodom, ispiranje vrućom vodom (80°C) poljevanje s 0,5% otopinom IzosanR (LEK - Ljubljana) obradom pomoću plina s 10% vodne otopine formaldehida. Tako raskužene objekte smo držali 14 dana zatvorenima. Uspješnost raskuživanja smo kontrolirali pomoću mikrobiološke analize uzetih brisova - 103 (Kohova metoda decimalnog razrjeđivanja, to je razrjeđivanje 1000). The facilities in which we housed the animals for testing were disinfected using the following activities: mechanical cleaning, rinsing with cold water, rinsing with hot water (80°C), spraying with a 0.5% solution of IzosanR (LEK - Ljubljana), processing using gas with 10% aqueous solutions of formaldehyde. We kept the facilities that were so exposed closed for 14 days. We controlled the success of the decontamination using the microbiological analysis of the swabs taken - 103 (Koch's method of decimal dilution, that is dilution 1000).
Za prostiranje smo upotrebljavali ljuske suncokreta u sloju 8 do 10 cm. Prostirku smo prije naseljenja pilića dezinficirali s 2% vodenom otopinom modre galice. Objekte smo grijali s plinskim grijačima te prozračivali ventilatorima, a temperaturu kontrolirali termostatima. Preporučena temperatura za brojlere prema normativu A A (Arbor - Acres) je slijedeća: For spreading, we used sunflower husks in a layer of 8 to 10 cm. We disinfected the mat with a 2% aqueous solution of blue galica before settling the chickens. The objects were heated with gas heaters and ventilated with fans, and the temperature was controlled with thermostats. The recommended temperature for broilers according to the norm A A (Arbor - Acres) is as follows:
Tjedan starosti Temperatura (°C) Week of age Temperature (°C)
1 32 - 35 1 32 - 35
2 29 - 32 2 29 - 32
3 26 - 29 3 26 - 29
4 23 - 26 4 23 - 26
5 21 - 23 5 21 - 23
6 21 6 21
7 21 7 21
Prema normativu A A iznosi dnevni utrošak vode u litrama na 100 brojlera doziran na različite temperature i starost: According to the norm A A is the daily water consumption in liters per 100 broilers dosed at different temperatures and ages:
Starost Količina utrošene vode u Age Amount of water used in
litrama kod temperature 21°C liters at a temperature of 21°C
1 30 1 30
2 60 2 60
3 91 3 91
4 121 4 121
5 155 5 155
6 185 6 185
Sastav upotrebljene hrane temeljio se na A A normativima: The composition of the food used was based on A A standards:
Početak Tok trajanja Završetak Start Duration End
0 - 23 dana 24 - 38 dana 38 - 42 dana (klanje) 0 - 23 days 24 - 38 days 38 - 42 days (slaughter)
Ukupni proteini % 23,0 20,5 18,5 Total proteins % 23.0 20.5 18.5
Ukupne masnoće% 5-7 5-7 5-7 Total fat % 5-7 5-7 5-7
Ca % 0,95-1,00 0,95-1,00 0,80-0,95 Ca % 0.95-1.00 0.95-1.00 0.80-0.95
P % 0,45-0,50 0,41-0,50 0,38-0,45 P % 0.45-0.50 0.41-0.50 0.38-0.45
NaCl % 0,30-0,50 0,30-0,50 0,30-0,50 NaCl % 0.30-0.50 0.30-0.50 0.30-0.50
Tjedan g The week of Mr
1 149 1 149
2 371 2 371
3 674 3 674
4 1040 4 1040
5 1458 5 in 1458
6 1900 6 in 1900
* Normativ AA (Arbor Acres) nazvan je prema firmi AAF Inc. Glastonbury Connecticut, najvećem američkom proizvodaču peradi. * The standard AA (Arbor Acres) is named after the company AAF Inc. Glastonbury Connecticut, America's largest poultry producer.
Težine pilića pratili smo vaganjem 1., 14., 21., 28., 35 dan te kod klanja (42 dan). We monitored the weight of the chickens by weighing them on the 1st, 14th, 21st, 28th, 35th day and at slaughter (42nd day).
Broj životinja i težine jednodnevnih pilića prema skupinama vidljiv je iz tabele 2. The number of animals and the weight of one-day-old chicks according to the groups can be seen from table 2.
Tabela 2 Table 2
Objekt Broj pilića Težina u gramima Facility Number of chicks Weight in grams
C 1 17 400 43 C 1 17 400 43
C 2 17 400 37 C 2 17 400 37
C 3 17 400 40 C 3 17 400 40
C 4 17 400 41 C 4 17 400 41
Iz tabele je vidljivo, da su bili na početku testova pilići najteži u objektu C 1, slijede pilići iz objekta C 4, a zatim C 3, dok su najlakši pilići bili u objektu C 2. Razlika između najveće i najmanje težine je 6 g. The table shows that at the beginning of the tests, the heaviest chickens were in facility C 1, followed by chickens from facility C 4, and then C 3, while the lightest chickens were in facility C 2. The difference between the highest and lowest weight is 6 g.
Zdravstveno stanje pilića prema skupinama pratili smo pomoću kliničkih patoanatomskih i bakterioloških pregleda. Svaki tjedan jednom uzeli smo uzorak unutarnjih organa pet životinja za bakteriološki pregled. We monitored the health condition of the chickens according to the groups using clinical pathoanatomical and bacteriological examinations. Every week, we took a sample of the internal organs of five animals for bacteriological examination.
Životinje smo vakcinirali u 14 dana starosti protiv atipične kokošje kuge (aplikacija u vodu). Animals were vaccinated at 14 days of age against atypical fowl disease (application in water).
Rezultati testiranja Test results
Rezultati vaganja pilića prvog dana starosti i daljnjim tjednima uzgoja prikazani su u tabeli 3. The results of weighing chickens on the first day of age and during further weeks of rearing are shown in Table 3.
Tabela 3 Table 3
Objekt Tjelesna masa Tjelesna masa Tjelesna masa Tjelesna masa Object Body mass Body mass Body mass Body mass
DSP (g) 1. tjedan 2. tjedan 3. tjedan DSP (g) 1st week 2nd week 3rd week
(N=149g) (N=371g) (N=674 g) (N=149g) (N=371g) (N=674g)
C 1 43 141 631 6666 C 1 43 141 631 6666
C 2 37 139 373 682 C 2 37 139 373 682
C 3 40 144 362 666 C 3 40 144 362 666
C 4 41 137 352 655 C 4 41 137 352 655
Objekt Tjelesna masa Tjelesna masa Tjelesna masa Object Body mass Body mass Body mass
(=1040g) 4. tjedan 5. tjedan (=1458g) 6. tjedan (=1040g) 4th week 5th week (=1458g) 6th week
C 1 1040 1466 1840 C 1 1040 1466 1840
C 2 1114 1490 1870 C 2 1114 1490 1870
C 3 996 1432 1850 C 3 996 1432 1850
C 4 986 1457 1770 C 4 986 1457 1770
N = normativ AA za tjelesnu masu u određenom vremenskom razdoblju. N = normative AA for body mass in a certain period of time.
DSP = dan stari pilići DSP = day old chicks
Tjedni prirast tjelesne mase pilića prema skupinama prikazan je u tabeli 3A: The weekly increase in body weight of chickens according to groups is shown in table 3A:
Tabela 3A: Table 3A:
Objekt Težina DSP Prirast tj. mase Prirast tj. mase Prirast tj. mase Object Weight DSP Increment i.e. mass Increment i.e. mass Increment i.e. mass
1. dan 1. tjedan (g) 2. tjedan (g) 3. tjedan (g) 1st day 1st week (g) 2nd week (g) 3rd week (g)
C 1 43 98 220 305 C 1 43 98 220 305
C 2 37 102 234 309 C 2 37 102 234 309
C 3 40 104 218 304 C 3 40 104 218 304
C 4 41 96 215 303 C 4 41 96 215 303
Objekt Prirast tj. mase Prirast tj. mase Prirast tj. mase Object Increase in mass Increase in mass Increase in mass
4. tjedan (g) 5. tjedan (g) 6. tjedan (g) 4th week (g) 5th week (g) 6th week (g)
C 1 374 426 374 C 1 374 426 374
C 2 432 376 380 C 2 432 376 380
C 3 430 436 418 C 3 430 436 418
C 4 331 471 313 C 4 331 471 313
Iz obiju tabela 3 i 3A vidljivo je, da u prvom tjednu pilići nijedne od pokusnih skupina nisu dostigli normative u tjelesnoj masi. Najveću tjelesnu masu postigli su pilići u objektu C 3, a najnižu u objektu C 4. It is evident from both tables 3 and 3A that in the first week the chickens of none of the experimental groups reached the standards in body weight. The highest body mass was achieved by chickens in facility C 3, and the lowest in facility C 4.
U drugom tjednu su imali najveću tjelesnu masu pilići iz objekta C 2, te su prekoračili normativ za 2 grama. U ostalim objektima pilići nisu dostigli normative u prirastu tjelesne mase. Pilići iz C 1 i C 3 objekta dostigli su približno jednaku težinu, te su bili oko 10 g ispod normativa. Opet su najmanju težinu imali pilići iz objekta C 4 i zaostajali su iza normativa 19 g. In the second week, the chickens from facility C 2 had the highest body mass, exceeding the norm by 2 grams. In the other facilities, the chickens did not reach the standards in terms of body weight gain. Chickens from C 1 and C 3 facilities reached approximately the same weight, and were about 10 g below the norm. Again, chickens from facility C 4 had the lowest weight and were behind the norm by 19 g.
U trećem tjednu su imali najveću težinu opet pilići iz objekta C 2, te su i jedini dostigli i prestigli normativ za 8 g. Pilići iz objekta C 1 i C 3 dostižu u istom vremenskom razdoblju potpuno jednaku težinu i to 8 g ispod normativa. In the third week, the chickens from facility C 2 had the highest weight, and they were the only ones to reach and surpass the norm by 8 g. The chickens from facility C 1 and C 3 reached exactly the same weight in the same period of time, 8 g below the norm.
Pilići u objektu C 4 imaju još uvijek najnižu težinu (19 g ispod normativa). Chickens in facility C 4 still have the lowest weight (19 g below the norm).
U četvrtom tjednu su pilići u objektu C 1 postigli tjelesnu masu prema normativu AA, a pilići iz objekta C 2 su je prešli za 74 g. Pilići iz C 3 objekta bili su 44 g ispod normativa, iz C 4 objekta pak za 54 g ispod normativa AA. In the fourth week, the chickens in facility C 1 reached the body weight according to the norm AA, and the chickens from facility C 2 exceeded it by 74 g. The chickens from facility C 3 were 44 g below the norm, from facility C 4 by 54 g below. norm AA.
U petom tjednu starosti su rezultati vaganja u C 2 objektu opet prestigli normativ AA i to za 32 g, u C 1 objektu samo za 8 g, tjelesna masa u C 3 i C 4 objektu nije dostigla normativ AA. Najveću konačnu tjelesnu težinu su postigli pilići iz C 2 objekta, iako su imali najnižu tjelesnu masu za vrijeme naseljenja. Prema podacima o tjelesnoj masi kod klanja slijedili su zatim C 3 i C 1 objekt, dok C 4 objekt odstupa od C 2 prema podatku o konačnoj tjelesnoj težini za 100 g. In the fifth week of age, the weighing results in the C 2 facility again exceeded the AA norm by 32 g, in the C 1 facility by only 8 g, the body mass in the C 3 and C 4 facility did not reach the AA norm. The highest final body weight was achieved by chickens from the C 2 facility, although they had the lowest body weight during settlement. According to data on body mass at slaughter, C 3 and C 1 object followed, while C 4 object deviates from C 2 according to data on final body weight by 100 g.
Podaci o konverziji hrane prikazani su u tabeli 4: Data on food conversion are shown in table 4:
(Konverzija nam pokazuje, koliko hrane je potrebno za 1 kg prirasta tjelesne mase) (The conversion shows us how much food is needed for 1 kg of body weight gain)
Tabela 4 Table 4
Objekt kg Object kg
C 1 1,96 C 1 1.96
C 2 1,96 C 2 1.96
C 3 1,94 C 3 1.94
C 4 2,05 C 4 2.05
U uzgoju pilića je vrlo značajan faktor konverzije. Conversion is a very important factor in raising chickens.
Iz gornje tabele vidimo, da su za 1 kg prirasta potrošili najmanje krmiva pilići iz C 3 objekta (1,94 kg), iz C 1 i C 2 objekta 0,2 g više, te iz C 4 objekta 0,11 g više krmiva. From the table above, we can see that for 1 kg of growth, chickens from C 3 facility consumed the least amount of feed (1.94 kg), from C 1 and C 2 facilities 0.2 g more, and from C 4 facility 0.11 g more feed. .
Podaci o tjednom uginuću pilića prema skupinama prikazani su u tabeli 5. Data on the weekly death of chickens according to groups are shown in table 5.
Tabela 5 Table 5
Starost Uginuće u obj. Uginuće u obj. Uginuće u obj. Uginuće u obj. Age Death in obj. He will die in obj. He will die in obj. He will die in obj.
(tjedni) C1 (%) C2 (%) C3 (%) C4 (%) (weeks) C1 (%) C2 (%) C3 (%) C4 (%)
1 1,85 0,56 0,44 0,60 1 1.85 0.56 0.44 0.60
2 0,63 0,52 0,40 0,60 2 0.63 0.52 0.40 0.60
3 0,59 0,69 0,95 0,81 3 0.59 0.69 0.95 0.81
4 0,93 0,79 1,85 0,69 4 0.93 0.79 1.85 0.69
5 0,99 0,77 1,12 0,71 5 0.99 0.77 1.12 0.71
6 1,21 1,30 1,24 1,93 6 1.21 1.30 1.24 1.93
ukupno 6,21 4,63 5,99 5,34 total 6.21 4.63 5.99 5.34
Za drugi i treći tjedan vidimo u tabeli prilično ujednačena uginuća po svim objektima. Isto tako ujednačena je bila klinička i patološka slika. Pilići su ugibali uglavnom radi kapi i ascitesa (vodenica), a i radi zahirenosti. Prema kraju trećeg tjedna primjećujemo u C 3 objektu nekoliko pilića sa bolešću natečenih glava i također nešto povećana uginuća (pilić ne vidi, ne dospije do vode i hrane i ugine). U četvrtom tjednu prema podacima o uginuću odskače objekt C 3. Prije smo spomenuli, da smo prema kraju trećeg tjedna primjetili piliće s otečenim glavama, broj ovih se jako povećao a time i uginuće. Kao drugi problem u tom objektu je nastupila kaheksija (oronulost). U ostalim objektima je glavni problem ascites i kaheksija. U šestom tjednu se općenito povisuju uginuća, pogotovo u objektu C 4, gdje dolazi do pojave klasičnog oblika CRD ("Chronic respiratore disease") pored toga još ascites i kaheksija. U C 3 objektu se broj primjera natečenih glava ustalio, a glavni problem su ascitesi i kaheksija, pored toga još i nekoliko primjera SRD. For the second and third week, we see in the table fairly uniform deaths across all facilities. The clinical and pathological picture was also uniform. Chickens died mainly due to dropsy and ascites (dropsy), and also due to indigestion. Towards the end of the third week, we notice in the C 3 facility several chickens with the disease of swollen heads and also somewhat increased deaths (the chicken cannot see, does not reach water and food and dies). In the fourth week, according to the mortality data, object C 3 jumps out. We mentioned before that towards the end of the third week, we noticed chickens with swollen heads, the number of these increased greatly, and thus the mortality. Another problem in that building was cachexia (deterioration). In other facilities, the main problem is ascites and cachexia. In the sixth week, deaths generally increase, especially in facility C 4, where the classic form of CRD ("Chronic respiratory disease") occurs, in addition to ascites and cachexia. In the C 3 facility, the number of cases of swollen heads has stabilized, and the main problem is ascites and cachexia, in addition to several cases of SRD.
Faktor uspješnosti uzgoja (I) Breeding success factor (I)
Usporedba podataka o ukupnom uginuću, konačnoj tjelesnoj masi, konverziji prema pojedinim grupama, prikazana je u tabeli 6. Comparison of data on total death, final body mass, conversion according to individual groups is shown in table 6.
Tabela 6 Table 6
C1 C2 C3 C4 C1 C2 C3 C4
ukupno uginuće (%) 6,21 4,63 5,99 5,34 total death (%) 6.21 4.63 5.99 5.34
konačna tjelesna masu (kg) 1,84 1,87 1,85 1,77 final body weight (kg) 1.84 1.87 1.85 1.77
konverzija 1,96 1,96 1,94 2,05 conversion 1.96 1.96 1.94 2.05
faktor uspješnosti 1,992 2,098 2,007 1,844 success factor 1.992 2.098 2.007 1.844
U tabeli 6 vidimo tri pokazatelja uspješnosti svakog uzgoja (uginuće, tjelesnu masu, konverziju). Ipak se može kod pregleda istih dobiti pogrešnu sliku uspješnosti nekog uzgoja. Radi toga imamo faktor uspješnosti, koji nam točno kaže, koji uzgoj je najuspješniji. U tabeli vidimo, da ima objekt C 2 najviši faktor uspješnosti, slijedi objekt C3, te C1 i C4. In table 6 we see three indicators of the success of each breeding (mortality, body mass, conversion). However, when examining them, one can get a wrong picture of the success of some cultivation. That's why we have a success factor, which tells us exactly which cultivation is the most successful. In the table we see that object C 2 has the highest success factor, followed by object C3, and C1 and C4.
Količina pridobivene mase, utrošak krmiva i količine izgubljenog mesa radi uginuća, prikazane su u tabeli 7. (preračunato na 1000 životinja). The amount of mass gained, feed consumption and the amount of meat lost due to death are shown in table 7 (calculated per 1000 animals).
Krmivo = težina x konverzija Feed = weight x conversion
meso = 71% od brojlera meat = 71% from broiler
Tabela 7 Table 7
C1 C2 C3 C4 C1 C2 C3 C4
Količina dobivenog The amount obtained
mesa (kg) 1306 1327 1313 1256 of meat (kg) 1306 1327 1313 1256
Utrošak hrane (kg) 3600 3660 3580 3628 Food consumption (kg) 3600 3660 3580 3628
Količina izgubljenog Amount lost
mesa radi, uginuća (kg) 80 61 77 66 for meat, deaths (kg) 80 61 77 66
U gornjoj tabeli vidimo, da sa prirastom tjelesne mase raste i utrošak krmiva. Iznimka je jedino C 4 objekat, gdje je usprkos niskoj težini, visok utrošak hrane. In the table above, we can see that with the increase in body weight, the consumption of feed also increases. The only exception is the C 4 facility, where, despite the low weight, the consumption of food is high.
Zakjučak Conclusion
Ukupna uginuća su najniža kod skupina, koja je dobivala kombinaciju antibiotika u smislu izuma, to je linkomicin-gentamicin (objekt C 2) 4,63%, slijedi amoksicilin trihidrat (objekt C 4) 5,43%, kombinacije linkomicin-spektinomicin (objekt C 3) 5,99 i zatim gentamicin (objekt C1) 6,21%. The total deaths are the lowest in the groups that received the combination of antibiotics according to the invention, i.e. lincomycin-gentamicin (object C 2) 4.63%, followed by amoxicillin trihydrate (object C 4) 5.43%, combinations of lincomycin-spectinomycin (object C 3) 5.99 and then gentamicin (object C1) 6.21%.
Konačna tjelesna masa je najveća pri skupini, koja je dobivala kombinaciju linkomicin-gentamicin (objekt C 2) 1,87 kg, slijedi kombinacija linkomicin-spektinomicin (objekt C 3) 1,85 kg, gentamicin (objekt C 1) 1,84 kg te zatim amoksicilin trihidrat (objekt C 4) 1,77 kg, što osjetljivo odstupa od ostalih triju skupina. The final body weight was the highest in the group receiving the combination of lincomycin-gentamicin (object C 2) 1.87 kg, followed by the combination lincomycin-spectinomycin (object C 3) 1.85 kg, gentamicin (object C 1) 1.84 kg and then amoxicillin trihydrate (object C 4) 1.77 kg, which deviates sensitively from the other three groups.
Faktor uspješnosti je najviši pri skupini, koja je dobivala kombinaciju antibiotika linkomicin - gentamicin (objekt C 2) zatim slijedi objekt C 3 te konačno C 1 i C 4. The success factor is highest in the group that received the antibiotic combination lincomycin - gentamicin (object C 2), followed by object C 3 and finally C 1 and C 4.
Konverzija je najniža kod skupine liječene kombinacijom linkomicin-spektinomicin (objekt C 3) 1,94 kg krmiva za 1 kg prirasta kod skupine, testiranoj kombinacijom antibiotika linkomicin-gentamicin, gdje je vrijednost konverzije 1,96, jednako kao i kod skupine testirane s gentamicinom. Skupina koja je bila liječena s antibiotikom amoksicilinom je utrošila najviše krmiva po kg prirasta (2,05). Conversion is the lowest in the group treated with the combination of lincomycin-spectinomycin (object C 3) 1.94 kg of feed for 1 kg of gain in the group tested with the antibiotic combination lincomycin-gentamicin, where the conversion value is 1.96, the same as in the group tested with gentamicin . The group that was treated with the antibiotic amoxicillin consumed the most feed per kg of gain (2.05).
Primjer 2 Example 2
Preparat za liječenje i uzgoj životinja Preparation for the treatment and breeding of animals
Linkomicin hidroklorid 360 g Lincomycin hydrochloride 360 g
Gentamicin sulfat 10 g Gentamicin sulfate 10 g
Polietilenglikol 4000 u prahu 40 g Polyethylene glycol 4000 in powder 40 g
Laktoza 590 g Lactose 590 g
1.000g 1,000 g
Preparat se priređuje mješanjem sitnozrnatih krutih sastojina u mješalici, koji možemo zatim dodati u pitku vodu ili u životinjsku hranu. The preparation is prepared by mixing fine-grained solid stands in a mixer, which can then be added to drinking water or animal feed.
Claims (9)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9200002A SI9200002B (en) | 1992-01-09 | 1992-01-09 | Cattle food and addition to it or to drinking water, containing antibiotic combination of gentamycine with lincomycine or clindamycine |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP930004A2 true HRP930004A2 (en) | 1994-08-31 |
HRP930004B1 HRP930004B1 (en) | 1999-10-31 |
Family
ID=20430921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP-9200002A HRP930004B1 (en) | 1992-01-09 | 1993-01-07 | Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin |
Country Status (5)
Country | Link |
---|---|
AT (1) | ATE171845T1 (en) |
DE (1) | DE69321429T2 (en) |
HR (1) | HRP930004B1 (en) |
SI (1) | SI9200002B (en) |
YU (1) | YU593A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114814012B (en) * | 2022-04-13 | 2023-06-23 | 浙江大学 | Determination method of lincolamine antibiotics in feed |
-
1992
- 1992-01-09 SI SI9200002A patent/SI9200002B/en unknown
-
1993
- 1993-01-05 AT AT93100072T patent/ATE171845T1/en not_active IP Right Cessation
- 1993-01-05 DE DE69321429T patent/DE69321429T2/en not_active Expired - Fee Related
- 1993-01-06 YU YU593D patent/YU593A/en unknown
- 1993-01-07 HR HRP-9200002A patent/HRP930004B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69321429D1 (en) | 1998-11-12 |
HRP930004B1 (en) | 1999-10-31 |
YU593A (en) | 1997-01-08 |
ATE171845T1 (en) | 1998-10-15 |
SI9200002B (en) | 1999-10-31 |
SI9200002A (en) | 1993-09-30 |
DE69321429T2 (en) | 1999-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DuPont et al. | Use of antimicrobial agents in animal feeds: implications for human health | |
Arnold et al. | Banning antimicrobial growth promoters in feedstuffs does not result in increased therapeutic use of antibiotics in medicated feed in pig farming | |
Hofacre et al. | Antimicrobial drug use in poultry | |
Tsiloyiannis et al. | The effect of organic acids on the control of post-weaning oedema disease of piglets | |
Tadesse et al. | Public health impacts of antibiotic residues in foods of animal origin: A review | |
PL191391B1 (en) | Orally administered product for preventing and treating gastrointestinal infections with swine and method of producing antibodies against pathogenes of such infections | |
US5516798A (en) | Method for treating diarrhea and a composition therefor | |
Loerch et al. | Use of trainer animals to improve performance and health of newly arrived feedlot calves | |
CN101011107A (en) | Pharmaceutical premixed agent for disease resistance and growth promotion and application thereof | |
HRP930004A2 (en) | Animal food, an additive to it, or to drinking water, containing the antibiotic mixture of gentamicin with lincomycin or clindamycin | |
EA032280B1 (en) | Methods and formulations for reducing bovine emissions | |
EP0585514B1 (en) | Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin | |
Spais et al. | Effect of Genex, a feed additive containing organic acids and herb extracts, on the performance of broiler chickens | |
Archer | Reducing stress in sheep by feeding the seaweed Ascophyllum nodosum | |
JPH11266796A (en) | Antimicrobial feed additive and antimicrobe by using the antimicrobial feed additive | |
JPH11299432A (en) | Feed additive for antimicrobial use and antimicrobial method | |
AU2009294602B2 (en) | Use of azaperone for reducing antibiotic usage | |
Smith | Salmonella food poisoning in human beings: the part played by domestic animals | |
Simitopoulou et al. | The Effect of the Targeted Application of Commercially Available Non-Antibiotic Additives in the Poultry Industry on Antibiotic Usage and Biological Performance under Commercial Field Conditions 8: 059 | |
Levy | Antibiotics, animals, and the resistance gene pool | |
US7176244B1 (en) | Use of 2-nitropropanol, 2-nitroethane, and 2-nitroethanol for control of microbial pathogens | |
RU2323730C1 (en) | Prophylaxis method of thrombocytopathy development in first hours of dyspepsia of newborn calves | |
US3271159A (en) | Feed compositions containing sodium nu-glycolylarsanilate and method of use | |
JP2021193979A (en) | Livestock first milk quality improver and method | |
Steidinger et al. | Comparison of different antimicrobial sequences on nursery pig performance and economic return |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20010107 Year of fee payment: 9 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20020108 |